Siliq (brodalumab) approved by the US FDA for adult patients with moderate-to-severe plaque psoriasis
Approval triggers $130 million milestone payment to AstraZeneca from US Partner Valeant Pharmaceuticals
Approval triggers $130 million milestone payment to AstraZeneca from US Partner Valeant Pharmaceuticals